We’re reimagining diagnostics by

READING THE IMMUNE SYSTEM

Host Response Diagnostics

Delivering precision medicine on demand

Inflammatix device with cartridge
SEE OUR PIPELINE

Product in development, is not for sale, and does not have marketing approval or clearance from regulatory authorities in any jurisdiction.

The power of reading the immune system to better diagnose disease

Dr. Tim Sweeney, Inflammatix Co-Founder and CEO

Product in development, is not for sale, and does not have marketing approval or clearance from regulatory authorities in any jurisdiction.

Product in development, is not for sale, and does not have marketing approval or clearance from regulatory authorities in any jurisdiction.

Our tests are addressing significant clinical needs in acute infection and sepsis diagnosis that affect millions of people

Products in development, not for sale, and do not have marketing approval or clearance from regulatory authorities in any jurisdiction.

Significant clinical needs in acute infection and sepsis diagnosis

In the News

Recent notable news stories

The Atlantic

Do Your Genes Know What’s Making You Sick?

January 6, 2022

frontiers in medicine

Artificial Intelligence for Clinical Decision Support in Sepsis

May 13, 2021

mddi Logo

Inflammatix Checks off All the Right Boxes with Investors

March 19, 2021

fierce biotech Logo

Inflammatix nets $102M to advance its immune system tests for infectious diseases

March 16, 2021

Also covered by

SEE ALL NEWS

Stay in touch with social updates:
Find out the latest news.

Follow us on Twitter
Follow us on LinkedIn